Hints and tips:
Related Special Reports
...They may also explore questions such as how the drugs can push people in the direction of eating healthier food....
...Advent and CVC were the two remaining investors competing in the process to acquire Partner in Pet Food, a Hungary-based maker of animal food....
...according to the Food and Drug Administration....
...The first mental health treatment using schedule-1 drug MDMA faces a significant regulatory hurdle as the US Food and Drug Administration is poised to ask outside experts to scrutinise it for post-traumatic...
...Leqembi, priced at $26,500 a year, was the first drug with a black-box warning — the most severe designation about possible side effects — to be granted full approval by the US Food and Drug Administration...
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...Ketamine has been approved by the US Food and Drug Administration for use as an anaesthetic since the 1970s. But more recently, specialist clinics have begun touting it as a mental health treatment....
...A decision from the US Food and Drug Administration on Eli Lilly’s donanemab drug was originally due by the end of the first quarter but the breakthrough medicine will now be subject to a further review...
...improvements that we think are going to unlock a lot of new science,” said John Jumper, DeepMind’s AlphaFold team leader, who cited the potential of the technique to improve knowledge of plant biology and thus food...
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
...A decision on Eli Lilly’s donanemab drug from the US Food and Drug Administration was originally due by the end of the first quarter, but the medicine will now be subject to a further review by an advisory...
...These will be the first results from a study designed around landmark US Food and Drug Administration guidelines for researching psychedelics that were outlined last year, a decision that encouraged investors...
...guidance from the Centers for Medicare and Medicaid Services (CMS)....
...According to a Food and Drug Administration database tracking drug shortages, lower doses of Wegovy have limited availability at present but higher doses and Ozempic injections are in good supply....
...families and caregivers — who face substantial wage loss and added expenses each year as the disease progresses — all while dealing with the unquantifiable anguish of losing their child,” said Bennett Smith...
...Pilot, which also operates the Flying J brand, sells fuel, food and merchandise to truckers and provides showers among other services....
...The US Food and Drug Administration on Friday approved the world’s first ever two gene therapies to treat patients with sickle cell disease....
...The US Food and Drug Administration says there is a shortage of Novo Nordisk’s and Eli Lilly’s diabetes drugs, while Belgium has banned the off-label use of Novo Nordisk’s diabetes drug for obesity treatments...
...Packaged food companies have built strong and trusted brands over decades....
...The US Food and Drug Administration last year approved over-the-counter sales of Narcan — the branded version of naloxone, a nasal spray used to reverse opioid overdoses — in the hope that greater access...
...The rush to secure manufacturing capacity comes as Wegovy and Mounjaro, which is also commonly prescribed off-label for weight loss, are in short supply, according to the US Food and Drug Administration....
...The US Food and Drug Administration has approved the first Alzheimer’s drug that can slow the progression of the neurodegenerative disease, paving the way for millions of American patients to access the...
...“Today’s approval addresses an unmet medical need,” said John Sharretts, director of the diabetes and obesity division in the FDA’s Center for Drug Evaluation and Research in a statement....
...Soleno Therapeutics, a rival biotech which is expected to file for US Food and Drug Administration approval for another treatment for Prader-Willi syndrome later this year, is currently valued at nearly...
...The mainstream adoption of weight-loss drugs poses a threat to industries from fast-food chains to hospital providers, according to credit strategists at Barclays, who warned that equities were pricing in...
International Edition